e-learning
resources
Milan 2017
Monday, 11.09.2017
Obstructive and central sleep apnoea: consequences and comorbidities
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Association between obstructive sleep apnoea (OSA) severity and metabolic disturbances
R. Plywaczewski (Warszawa, Poland)
Source:
International Congress 2017 – Obstructive and central sleep apnoea: consequences and comorbidities
Session:
Obstructive and central sleep apnoea: consequences and comorbidities
Session type:
Thematic Poster
Number:
2320
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
R. Plywaczewski (Warszawa, Poland). Association between obstructive sleep apnoea (OSA) severity and metabolic disturbances. 2320
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Static lung volumes and spirometry measurements
Panel discussion: The role of pharmacotherapy connected to OSA pathophysiological traits
Expert interview ERS guideline on non-CPAP therapies in obstructive sleep apnoea
Related content which might interest you:
Association between metabolic disturbances and inflammatory markers in obstructive sleep apnea (OSAS) patients
Source: Annual Congress 2008 - Metabolic syndrome and systemic inflammation in obstructive sleep apnoea
Year: 2008
Metabolic disturbances in overlap syndrome (obstructive sleep apnoea + chronic obstructive pulmonary disease) and obstructive sleep apnoea (OSA) patients
Source: Annual Congress 2010 - Clinical aspects of sleep apnoea
Year: 2010
Association between obstructive sleep apnea hypopnea and metabolic syndromes
Source: Eur Respir J 2004; 24: Suppl. 48, 692s
Year: 2004
Prevalence of nocturia in obstructive sleep apnoea (OSA)
Source: Eur Respir J 2006; 28: Suppl. 50, 646s
Year: 2006
Prevalence of stroke in obstructive sleep apnoea (OSA) patients
Source: Eur Respir J 2007; 30: Suppl. 51, 331s
Year: 2007
Prevalence of cardiorespiratory disease increase with increasing severity of obstructive sleep apnoea (OSA)
Source: Eur Respir J 2002; 20: Suppl. 38, 322s
Year: 2002
Prevalence of complex sleep apnea among German patients with obstructive sleep apnea
Source: Annual Congress 2009 - Socio-economic and epidemiological aspects of sleep apnoea
Year: 2009
Association between daytime hypersomnolence and the metabolic syndrome in men with obstructive sleep apnea
Source: Annual Congress 2009 - Clinical aspects of sleep apnoea
Year: 2009
Asthma, obesity, metabolic dysfunction and obstructive sleep apnoea
Source: International Congress 2019 – State of the art session: Sleep and breathing disorders
Year: 2019
Effect of obstructive sleep apnea syndrome (OSAS) on cognitive performances
Source: Annual Congress 2009 - Systemic consequences of sleep-disordered breathing
Year: 2009
Increased rates of obstructive sleep apnea (OSA) in COVID-19-patients
Source: Virtual Congress 2021 – Sleep across the lifespan in the new era of COVID - 19
Year: 2021
The effect of concomitant COPD on obstructive sleep apnea syndrome severity and sleep structure
Source: Annual Congress 2011 - Obstructive sleep apnoea as a comorbidity
Year: 2011
Metabolic syndrome in obstructive sleep apnoea patients
Source: Annual Congress 2007 - Sleep apnoea
Year: 2007
Degree of sleepiness and cardiac alterations in non-hypertensive obstructive sleep apnea (OSA) patients
Source: Annual Congress 2009 - Cardiovascular complications in obstructive sleep apnoea
Year: 2009
Obesity, obstructive sleep apnea (OSA) and asthma
Source: Annual Congress 2009 - Asthma and comorbid conditions
Year: 2009
Incidence of cardiovascular complications in overlap syndrome (obstructive sleep apnoea + chronic obstructive pulmonary disease) and obstructive sleep apnoea (OSA)
Source: Annual Congress 2007 - Sleep apnoea in cardiorespiratory disorders
Year: 2007
Comparison of plasma NT-proBNP level in overlap syndrome (obstructive sleep apnoea + chronic obstructive pulmonary disease) and obstructive sleep apnoea (OSA)
Source: Annual Congress 2008 - Control of breathing and respiratory disorders during sleep
Year: 2008
Predictors of hypercapnia in obstructive sleep apnoea (OSA)
Source: Annual Congress 2010 - Lung disease and mountain sickness: the importance of ventilatory control
Year: 2010
Cortisol metabolism in obstructive sleep apnea (OSA)
Source: Eur Respir J 2002; 20: Suppl. 38, 215s
Year: 2002
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept